Building markets and brands from the ground up,
fully realizing products’ clinical and commercial value

Business Introduction

CMS focuses on advantaged specialty areas including Cardiovascular-Kidney-Metabolic, central nervous system, gastroenterology, ophthalmology, and skin health. Through professional academic promotion and academic resources across multiple disease areas, it has built scale advantages in specialties, with its skin health business becoming a leading player in its segment.

Leveraging its core capability to build markets and brands from the ground up, the Group continues to create and cultivate markets so that innovative products can truly enter clinical practice and serve patients. Across key steps such as market access, medical education, and academic promotion, it has established a nationwide professional academic promotion system and continues to enhance an omnichannel commercialization network that coordinates both in-hospital and out-of-hospital settings—ensuring continuous value realization throughout the product lifecycle.

CMS continues to strengthen its international replication capabilities, validating the transferability of its business model in emerging markets such as Southeast Asia and the Middle East, and injecting strong momentum for high-quality, sustainable development.

~5,000

Professional Academic Promotion Personnel

>55,000
Chinese Hospitals/Medical Institutions Covered in Sales Network
~320,000
Chinese Drugstores Covered in Sales Network
7
Major E-commerce and O2O Platforms Covered in Sales Network

*As at 31 December 2025

Cardio-cerebrovascular and Gastroenterology Business

 

Focusing on life-threatening and chronic diseases in the Cardiovascular-Kidney-Metabolic and gastrointestinal fields to safeguard the lives of patients

Dermatology and Medical Aesthetic Business

 

Focusing on unmet skin treatment and care needs, we provide professional and quality products to achieve healthy and beautiful skin

Ophthalmology Business

 

Focused on the ophthalmology specialty field, sourcing and developing globally innovative products that address urgent clinical needs, and building a medical-grade eye health ecosystem

Southeast Asia & the Middle East Business

 

Industrial internationalization of the fully integrated “R&D-Manufacturing-Commercialization” value chain, establish a hub for innovative drugs to enter emerging overseas markets

Innovation

Learn more

Major Marketed Products

Learn more